Back to discover
Disease

Chromosome Deletion

Clinical development underwayEmerging research
MeSHChromosome Deletion
1
Publications
1
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
0
Late-stage
1
Completed
Recently completed

A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)

Phase 1 · Completed · National Human Genome Research Institute (NHGRI)

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes2
  • Autism Spectrum Disorder1
  • Problem Behavior1
Leading journals1
  • Molecular autism1
Leading researchers8
  • Albanesi M1
  • Bauer HF1
  • Boeckers TM1
  • Landi S1
  • Nardi G1
  • Pagano J1
  • Pracucci E1
  • Ratto GM1
Affiliations (unnormalised)3
  • Institute for Anatomy and Cell Biology1
  • Neuroscience Institute1
  • Padova Neuroscience Center1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Actual loss of portion of a chromosome.

Identifiers
MeSHChromosome Deletion
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.